ExLibris header image
SFX Logo
Title: Pathogenomics of non-pathogens
Source:

Nature Reviews Microbiology [1740-1526] Holden, Matthew yr:2004


Collapse list of basic services Basic
Full text
Full text available via Nature
GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Chetrit, Hirsh-Yechezkel, Ben-David, Lubin, Friedm, A. "Effect of BRCA1/2 Mutations on Long-Term Survival of Patients With Invasive Ovarian Cancer: The National Israeli Study of Ovarian Cancer." Journal of clinical oncology 26.1 (2007): 20-25. Link to SFX for this item
2. Hoskins, W J J. "Clinicopathologic features of BRCA-linked and sporadic ovarian cancer." JAMA 283.17 (2000): 2260-5. Link to SFX for this item
3. Trainer, Alison H. "The role of BRCA mutation testing in determining breast cancer therapy." Nature Reviews Clinical Oncology 7.12 (2010): 708-17. Link to SFX for this item
4. Elit, L. "It's a choice to move forward: Women's perceptions about treatment decision making in recurrent ovarian cancer." Psycho-oncology 19.3 (2010): 318-325. Link to Full Text for this item Link to SFX for this item
5. Chapman, Dianne D D. "Cancer genetics." Seminars in oncology nursing 23.1 (2007): 2-9. Link to SFX for this item
6. Heintz, F. "Specialized care and survival of ovarian cancer patients in The Netherlands: nationwide cohort study." Journal of the National Cancer Institute 100.6 (2008): 399-406. Link to SFX for this item
7. Rubin, S C C. "Clinical and Pathological Features of Ovarian Cancer in Women with Germ-Line Mutations of BRCA1." New England Journal of Medicine, The 335.19 (1996): 1413-1416. Link to SFX for this item
8. Narod, Steven A. "BRCA mutations in the management of breast cancer: the state of the art." Nature Reviews Clinical Oncology 7.12 (2010): 702-707. Link to SFX for this item
9. Vernooij, F. "The outcomes of ovarian cancer treatment are better when provided by gynecologic oncologists and in specialized hospitals: a systematic review." Gynecologic Oncology 105.3 (2007): 801-12. Link to SFX for this item
10. Ziegler, J. "Uptake, Time Course, and Predictors of Risk-Reducing Surgeries in BRCA Carriers." Genetic testing and molecular biomarkers 13.1 (2009): 51-56. Link to SFX for this item
11. Murphy, Conleth G. "BRCA gene structure and function in tumor suppression: a repair-centric perspective." The cancer journal 16.1 (2010): 39-47. Link to SFX for this item
12. Boss, D. "Inhibition of Poly(ADP-Ribose) Polymerase in Tumors from BRCA Mutation Carriers." New England Journal of Medicine, The 361.2 (2009): 123-134. Link to SFX for this item
13. Lahad, E. "Cancer risks among BRCA1 and BRCA2 mutation carriers." The British journal of cancer 96.1 (2007): 11-5. Link to Full Text for this item Link to SFX for this item
14. Holschneider, C H H. "Ovarian cancer: epidemiology, biology, and prognostic factors." Seminars in surgical oncology 19.1 (2000): 3-10. Link to Full Text for this item Link to SFX for this item
15. Buckley, Niamh E. "BRCA1 - Conductor of the Breast Stem Cell Orchestra: The Role of BRCA1 in Mammary Gland Development and Identification of Cell of Origin of BRCA1 Mutant Breast Cancer." Stem Cell Reviews and Reports 8.3 (2012): 982-993. Link to SFX for this item
16. Salhab, M. "Risk-reducing strategies for women carrying BRCA1/2 mutations with a focus on prophylactic surgery." BMC women's health 10.1 (2010): 28-28. Link to Full Text for this item Link to SFX for this item
17. Rehman, F. "Synthetic lethal approaches to breast cancer therapy." Nature Reviews Clinical Oncology 7.12 (2010): 718-724. Link to SFX for this item
18. Metzger-Filho, O. "First-line systemic treatment of ovarian cancer: a critical review of available evidence and expectations for future directions." Current opinion in oncology 22.5 (2010): 513-520. Link to SFX for this item
19. Chi DS, Palayekar MJ, Sonoda Y, Abu-Rustum NR, Awt, Dennis S. "Nomogram for survival after primary surgery for bulky stage IIIC ovarian carcinoma." Gynecologic Oncology 108.1 (2007): 191-194. Link to SFX for this item
20. SM, H. "Inequality of use of Cancer Genetics Services by members of breast, ovarian and colorectal cancer families in South East Scotland." Familial cancer 7.3 (2008): 259-64. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced
A service provided by the Library of the Wissenschaftspark Albert Einstein, Potsdam, Germany.
© 2005 SFX by Ex Libris Inc.